Inari Medical Reports Fourth Quarter and Full Year 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Inari Medical Inc. (NARI) PT Lowered to $108 at Morgan Stanley
February 24, 2022 8:55 AM ESTMorgan Stanley analyst Cecilia Furlong lowered the price target on Inari Medical Inc. (NASDAQ: NARI) to $108.00 (from $119.00) while maintaining a Overweight rating.
... MoreInari Medical, Inc. (NARI) Misses Q4 EPS by 1c
February 23, 2022 4:54 PM ESTInari Medical, Inc. (NASDAQ: NARI) reported Q4 EPS of $0.02, $0.01 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $83.2 million versus the consensus estimate of $78.16 million.
For earnings history and earnings-related data on Inari Medical, Inc. (NARI) click here.
... More